Cell-free biotech enables shelf-stable vaccines on demand
The project is the latest iteration of an ongoing collaboration between Matthew DeLisa, the William L. Lewis Professor in the Smith School of Chemical and Biomolecular Engineering and director of the... Read more about Cell-free biotech enables shelf-stable vaccines on demand